Pipeline
Interface Bio’s approach brings value across the entire drug development chain
01
Discovery
01
Discovery
01
Discovery
02
Development
02
Development
02
Development
03
Clinical Trials
03
Clinical Trials
03
Clinical Trials
Why are natural products an ideal starting point for therapeutics?
01
Safe
By sourcing natural products from commensal microbes, we are choosing molecules that have been already proven to be safe. In fact, they are sitting on our skin and running through our veins right now.
01
Safe
By sourcing natural products from commensal microbes, we are choosing molecules that have been already proven to be safe. In fact, they are sitting on our skin and running through our veins right now.
01
Safe
By sourcing natural products from commensal microbes, we are choosing molecules that have been already proven to be safe. In fact, they are sitting on our skin and running through our veins right now.
02
Effective
Commensal derived natural products are evolutionarily pressured to modulate the immune system to avoid death (via dampening the immune system) and eliminate competition (via activating the immune system). This gives rise to a library of diverse natural products for the treatment of many types of inflammatory and oncology indications.
02
Effective
Commensal derived natural products are evolutionarily pressured to modulate the immune system to avoid death (via dampening the immune system) and eliminate competition (via activating the immune system). This gives rise to a library of diverse natural products for the treatment of many types of inflammatory and oncology indications.
02
Effective
Commensal derived natural products are evolutionarily pressured to modulate the immune system to avoid death (via dampening the immune system) and eliminate competition (via activating the immune system). This gives rise to a library of diverse natural products for the treatment of many types of inflammatory and oncology indications.
03
Synergistic
Natural products evolved within humans for tens of millions of years to develop multi-functional molecules that not only modulate the immune system on its own, but also activate synergistic pathways within the inflammatory cascade to create more potent therapeutics.
03
Synergistic
Natural products evolved within humans for tens of millions of years to develop multi-functional molecules that not only modulate the immune system on its own, but also activate synergistic pathways within the inflammatory cascade to create more potent therapeutics.
03
Synergistic
Natural products evolved within humans for tens of millions of years to develop multi-functional molecules that not only modulate the immune system on its own, but also activate synergistic pathways within the inflammatory cascade to create more potent therapeutics.
Drug Discovery
Our Pipeline
Our drug pipeline is focused on getting our lead and secondary assets to clinic quickly, while simultaneously expanding to adjacent inflammatory and cancer indications
Program
Target/MoA
Therapeutic Areas
Discovery
Optimization
IND-enabling
Clinical
IFB01
Innate Immune Activation
Innate immune deficiency disorders
Inflammation
Oncology
IFB02
CCL20 and CXCL10 Ablation
Rheumatoid Arthritis
Inflammatory Bowel Disease
Oncology Applications
IFB03
IL6 Induction
Wound healing
IFBe04
Peptide Stability
Gut restricted oral therapeutic
Drug Discovery
Our Pipeline
Our drug pipeline is focused on getting our lead and secondary assets to clinic quickly, while simultaneously expanding to adjacent inflammatory and cancer indications
Discovery
Optimization
IND-enabling
Clinical
IFB01
Innate Immune Activation
Innate immune deficiency disorders
Inflammation
Oncology
IFB02
CCL20 and CXCL10 Ablation
Rheumatoid Arthritis
Inflammatory Bowel Disease
Oncology Applications
IFB03
IL6 Induction
Wound healing
IFBe04
Peptide Stability
Gut restricted oral therapeutic
Drug Discovery
Our Pipeline
Our drug pipeline is focused on getting our lead and secondary assets to clinic quickly, while simultaneously expanding to adjacent inflammatory and cancer indications
Discovery
Optimization
IND-enabling
Clinical
IFB01
Innate Immune Activation
Innate immune deficiency disorders
Inflammation
Oncology
IFB02
CCL20 and CXCL10 Ablation
Rheumatoid Arthritis
Inflammatory Bowel Disease
Oncology Applications
IFB03
IL6 Induction
Wound healing
IFBe04
Peptide Stability
Gut restricted oral therapeutic
Drug Discovery
Our Pipeline
Our drug pipeline is focused on getting our lead and secondary assets to clinic quickly, while simultaneously expanding to adjacent inflammatory and cancer indications
Discovery
Optimization
IND-enabling
Clinical
IFB01
Innate Immune Activation
Innate immune deficiency disorders
Inflammation
Oncology
IFB02
CCL20 and CXCL10 Ablation
Rheumatoid Arthritis
Inflammatory Bowel Disease
Oncology Applications
IFB03
IL6 Induction
Wound healing
IFBe04
Peptide Stability
Gut restricted oral therapeutic
Learn more about our science and expertise in sactipeptides
See how sactipeptides are different and the key to effective therapeutics
